Compass Therapeutics, Inc. (CMPX) vs Organogenesis Holdings Inc. (ORGO)
A side-by-side comparison of Compass Therapeutics, Inc. and Organogenesis Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CMPX
Compass Therapeutics, Inc.
$0.97HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
ORGO
Organogenesis Holdings Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — CMPX vs ORGO
growth of $100 · dividends reinvested · last 6yCMPX -88.7% (-30.5%/yr)ORGO -92.9% (-35.7%/yr)CMPX compounded faster over this window
CMPX ORGO
CMPX vs ORGO: by the numbers
- •CMPX is the larger company ($175M vs $170M market cap).
- •Both run net losses; CMPX's is the smaller (0.00% vs -19.76% net margin).
Metrics side by side
Valuation
| Metric | CMPX | ORGO |
|---|---|---|
| P/S ratio | N/A | 0.37 |
| P/B ratio | 1.06 | 1.15 |
| EV / EBITDA | N/A | 214.03 |
| FCF yield | N/A | 12.27% |
Profitability
| Metric | CMPX | ORGO |
|---|---|---|
| Gross margin | 0.00% | 67.59% |
| Operating margin | 0.00% | 9.92% |
| Net margin | 0.00% | -19.76% |
| ROE | -44.23% | -31.32% |
| ROIC | -46.59% | -8.34% |
Growth (annualized)
| Metric | CMPX | ORGO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.05% |
| FCF CAGR (5Y) | N/A | -5.54% |
| Total return CAGR (5Y) | -22.79% | -37.41% |
Frequently asked
- How have CMPX and ORGO total returns compared?
- Over the past 5 years, CMPX delivered -22.79% and ORGO delivered -37.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Compass Therapeutics ROEOrganogenesis ROECompass Therapeutics operating marginOrganogenesis operating marginCompass Therapeutics revenue growthOrganogenesis revenue growthCompass Therapeutics free cash flowOrganogenesis free cash flow
Compass Therapeutics & Organogenesis appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.